These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 16539660
21. Down's syndrome individuals begin life with normal levels of brain cholinergic markers. Kish S, Karlinsky H, Becker L, Gilbert J, Rebbetoy M, Chang LJ, DiStefano L, Hornykiewicz O. J Neurochem; 1989 Apr; 52(4):1183-7. PubMed ID: 2522539 [Abstract] [Full Text] [Related]
22. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase. Fu AL, Li Q, Dong ZH, Huang SJ, Wang YX, Sun MJ. Neurosci Lett; 2004 Sep 30; 368(3):258-62. PubMed ID: 15364407 [Abstract] [Full Text] [Related]
23. Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. Sigala S, Zoli M, Palazzolo F, Faccoli S, Zanardi A, Mercuri NB, Spano P. Neuroscience; 2007 Feb 09; 144(3):834-44. PubMed ID: 17112676 [Abstract] [Full Text] [Related]
24. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giuliani A, Calzà L, Bartesaghi R. Brain; 2014 Feb 09; 137(Pt 2):380-401. PubMed ID: 24334313 [Abstract] [Full Text] [Related]
25. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome. Hijazi M, Fillat C, Medina JM, Velasco A. Exp Neurol; 2013 Jan 09; 239():229-34. PubMed ID: 23124096 [Abstract] [Full Text] [Related]
26. Stimulation of choline acetyltransferase by C3d, a neural cell adhesion molecule ligand. Burgess A, Saini S, Weng YQ, Aubert I. J Neurosci Res; 2009 Feb 15; 87(3):609-16. PubMed ID: 18855942 [Abstract] [Full Text] [Related]
27. Down's syndrome and Alzheimer's dementia: defining an association. Heston LL. Psychiatr Dev; 1984 Feb 15; 2(4):287-94. PubMed ID: 6241313 [Abstract] [Full Text] [Related]
28. Selective loss of basal forebrain cholinergic neurons in APP770 transgenic mice. Li H, Shen X. Chin Med J (Engl); 2000 Nov 15; 113(11):1040-2. PubMed ID: 11776121 [Abstract] [Full Text] [Related]
29. Ciliary neurotrophic factor (CNTF) genotypes: influence on choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) activities and neurotrophin 3 (NT3) concentration in human post mortem brain tissue. Thome J, Nara K, Foley P, Michel T, Gsell W, Retz W, Rosler M, Riederer P. J Hirnforsch; 1997 Nov 15; 38(4):443-51. PubMed ID: 9476208 [Abstract] [Full Text] [Related]
30. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome. Hunter CL, Bachman D, Granholm AC. Ann Neurol; 2004 Nov 15; 56(5):675-88. PubMed ID: 15468085 [Abstract] [Full Text] [Related]
31. The vanadium (IV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K. Neuroscience; 2008 Feb 06; 151(3):671-9. PubMed ID: 18164824 [Abstract] [Full Text] [Related]
32. 82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease. Gill SK, Ishak M, Dobransky T, Haroutunian V, Davis KL, Rylett RJ. Neurobiol Aging; 2007 Jul 06; 28(7):1028-40. PubMed ID: 16797789 [Abstract] [Full Text] [Related]
33. A model for dynamic regulation of choline acetyltransferase by phosphorylation. Dobransky T, Rylett RJ. J Neurochem; 2005 Oct 06; 95(2):305-13. PubMed ID: 16135099 [Abstract] [Full Text] [Related]
34. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome. Corrales A, Martínez P, García S, Vidal V, García E, Flórez J, Sanchez-Barceló EJ, Martínez-Cué C, Rueda N. J Pineal Res; 2013 Apr 06; 54(3):346-58. PubMed ID: 23350971 [Abstract] [Full Text] [Related]
35. Overexpression of tumour necrosis factor alpha in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyltransferase activity. Aloe L, Fiore M, Probert L, Turrini P, Tirassa P. Cytokine; 1999 Jan 06; 11(1):45-54. PubMed ID: 10080878 [Abstract] [Full Text] [Related]
36. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M. Ann Neurol; 1989 Sep 06; 26(3):362-7. PubMed ID: 2802535 [Abstract] [Full Text] [Related]
37. Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Kelley CM, Powers BE, Velazquez R, Ash JA, Ginsberg SD, Strupp BJ, Mufson EJ. Brain Pathol; 2014 Jan 06; 24(1):33-44. PubMed ID: 23802663 [Abstract] [Full Text] [Related]
38. Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome. Kurt MA, Kafa MI, Dierssen M, Davies DC. Brain Res; 2004 Oct 01; 1022(1-2):101-9. PubMed ID: 15353219 [Abstract] [Full Text] [Related]
39. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Rueda N, Flórez J, Martínez-Cué C. Neurosci Lett; 2008 Mar 05; 433(1):22-7. PubMed ID: 18226451 [Abstract] [Full Text] [Related]
40. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Granholm AC, Sanders L, Seo H, Lin L, Ford K, Isacson O. Hippocampus; 2003 Mar 05; 13(8):905-14. PubMed ID: 14750653 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]